Fibrocor Therapeutics Inc. ('Fibrocor' or 'the Company'), a biotech company developing first-in-class therapies for kidney diseases, with a strong focus on Alport Syndrome, today announces the ...

Overall response rate (ORR) in triple combo study with azacitidine and venetoclax in newly diagnosed AML patients80% CR and ...

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide four NHS trusts with a single enterprise imaging solution delivered as a cloud service, Sectra One Cloud.

Scarcell Therapeutics, an innovator in cell therapies to treat chronic degenerative inflammatory diseases, today announced the world's first patients treated with its Allogenic Gingival Fibroblast ...

MS. COOPER: Good morning, and welcome to The Washington Post. I’m Gina Cooper, managing director of Washington Post Live. Thank you so much to everyone who’s here in the room joining us this morning ...

Codetta Bio™, a leading innovator in multi-omic solutions that integrate ultrasensitive protein quantitation with simultaneous analysis of nucleic acids (RNA and DNA), ...

This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...

Roundup was first brought to market by Monsanto in 1974. Its active ingredient, glyphosate, had been rediscovered by chemists Phil Hamm and John Franz four years prior – it had first been synthesized ...

A collaborative approach to cancer research and innovation has placed the island of Ireland above many of its European ...

The IMD Startup Competition has selected 13 startups to collaborate with participants in the Executive MBA. The competition is an annual event that highlights high-potential Swiss ventures, giving ...